Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene expression-based, individualized diagnostic GC/ABC prediction for relapse/refractory diffuse large B cell lymphoma (DLBCL)

ABSTRACT: Individualized diagnosis prediction classifiers were successfully constructed through expression profiling of a total of 8,644 genes in 49 patients with relapse/refractory diffuse large B cell lymphoma, prospectively treated in a randomized trial. keyword(s): Diagnosis prediction All lymphoma cases were predicted as belonging either to germical center B-cell like DLBCL or activated B cell like DLBCL based on the expression of a set of 54 genes (140 probes).

ORGANISM(S): Homo sapiens

SUBMITTER: Edouard Hirchaud 

PROVIDER: E-GEOD-26812 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.

Thieblemont Catherine C   Briere Josette J   Mounier Nicolas N   Voelker Hans-Ullrich HU   Cuccuini Wendy W   Hirchaud Edouard E   Rosenwald Andreas A   Jack Andrew A   Sundstrom Christer C   Cogliatti Sergio S   Trougouboff Philippe P   Boudova Ludmila L   Ysebaert Loic L   Soulier Jean J   Chevalier Catherine C   Bron Dominique D   Schmitz Norbert N   Gaulard Philippe P   Houlgatte Remi R   Gisselbrecht Christian C  

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110926 31

<h4>Purpose</h4>To evaluate the prognostic value of the cell of origin (COO) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBLC), prospectively treated by rituximab, dexamethasone, high-dose cytarabine, and cisplatin (R-DHAP) versus rituximab, ifosfamide, carboplatin, and etoposide and followed by intensive therapy plus autologous stem-cell transplantation on the Collaborative Trial in Relapsed Aggressive Lymphoma (CORAL) trial.<h4>Patients and methods</h4>Among the 396 pa  ...[more]

Similar Datasets

Transcriptomics Gene expression-based, individualized diagnostic GC/ABC prediction for relapse/refractory diffuse large B cell lymphoma (DLBCL)
2011-09-29 | GSE26812 | GEO
Proteomics A multiomics approach in refractory DLBCL
2019-03-04 | PXD009089 | Pride
Transcriptomics FOXP1 in ABC DLBCL
2015-12-01 | GSE64586 | GEO
Transcriptomics Co-addiction to IRF4 and SPIB in ABC-DLBCL
2012-08-16 | GSE32456 | GEO
Transcriptomics DFBL-18689-V2 PDX (ABC-DLBCL) tumors treated with miR-28 or control mimics
2023-09-21 | GSE229786 | GEO
Transcriptomics Longitudinal gene expression profiling identifies a poor risk subset of patients with ABC-type Diffuse Large B Cell Lymphoma
2023-03-08 | GSE193566 | GEO
Transcriptomics Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
2012-08-16 | GSE33012 | GEO
Transcriptomics Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
2012-08-16 | E-GEOD-33012 | biostudies-arrayexpress
Genomics Epigenomic Evolution of Diffuse Large B-cell Relapse
2015-04-14 | E-GEOD-66329 | biostudies-arrayexpress
Transcriptomics Transcriptional profiling of murine ABC-DLBCL-like tumors [RNA-seq]
2019-04-19 | GSE116288 | GEO